Roger Dansey - 03 Jan 2022 Form 4 Insider Report for Seagen Inc. (SGEN)

Role
Chief Medical Officer
Signature
By: /s/ Jennifer Prosba For: Roger D. Dansey
Issuer symbol
SGEN
Transactions as of
03 Jan 2022
Transactions value $
-$1,323,648
Form type
4
Filing time
05 Jan 2022, 16:32:11 UTC
Previous filing
22 Dec 2021
Next filing
04 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGEN Common Stock Sale -$529K -3.47K -3.93% $152.58 84.9K 03 Jan 2022 Direct F1, F2
transaction SGEN Common Stock Sale -$529K -3.47K -4.09% $152.58 81.4K 03 Jan 2022 Direct F1, F2
transaction SGEN Common Stock Sale -$265K -1.74K -2.13% $152.58 79.7K 03 Jan 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.